Nanette C Schloot
Nanette C Schloot is an expert in Endocrinology at Eli Lilly (Germany) (Germany). As of July 2026, ScienceLeadR ranks Nanette C Schloot in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Nanette C Schloot has authored 200 publications, the most recent in 2026, and is an investigator in 7 clinical trials. SLR score: 640 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Cardiology - Gastroenterology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1995 - 2025
Number : 200
Citations
Main journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Transcriptomics of type 1 diabetes progression: a validation study in newly diagnosed patients. PMID 42413288 — diabetes mellitus, genes, biomedical research, disease progression, diagnosis, therapeutics, diabetes mellitus, type 1, gene expression | EBioMedicine | 2026 | 0 |
| Association of Long-Term Body Mass Index Variability With the Development of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction Across Patterns of Weight Change. PMID 40932106 — longitudinal studies, heart diseases, body mass index, heart failure, heart, weight gain, heart failure, diastolic, heart failure, systolic, obesity, weight loss, overweight | J Am Heart Assoc | 2025 | 0 |
| Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial. PMID 40609566 — diabetes mellitus, pharmaceutical preparations, body composition, drug-related side effects and adverse reactions, weight loss, glucagon, therapeutics, glucagon-like peptides, diabetes mellitus, type 2 | Lancet Diabetes Endocrinol Top journal | 2025 | 6 |
| Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria. PMID 39529211 — diabetes mellitus, registries, hypertension, peripheral nervous system diseases, cardiovascular diseases, dyslipidemias, prevalence, diagnosis, diabetes mellitus, type 1, diabetes mellitus, type 2 | Diabetes Obes Metab | 2024 | 2 |
| Typ-1-Diabetes: Wie gut sind junge Kriegsflüchtlinge eingestellt? OpenAlex W4403666908 — diabetes mellitus | Info Diabetologie | 2024 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map